Navigation Links
Nobel laureate to keynote international pharmaceutical conference at URI
Date:6/7/2012

KINGSTON, R.I. June 7, 2012 The University of Rhode Island will hold a global pharmaceutical sciences conference featuring Nobel Prize winner Thomas Steitz from Sept. 28 through 30 at its Kingston Campus.

Steitz, the Sterling Professor of Molecular Biophysics and Biochemistry and professor of chemistry at Yale University, will speak Sunday, Sept. 30 at 9 a.m. Steitz, who was awarded the Nobel Prize for Chemistry in 2009 with two other scientists, is also an investigator at Yale's Howard Hughes Medical Institute.

Registration is required and full details about the conference can be found at http://www.uri.edu/pharmacy/frontiers/2012/index.html. The program is one of many to be held in conjunction with the September grand opening of the new URI College of Pharmacy building, a $75 million facility supported primarily by Rhode Islanders.

Conference co-organizer Navindra Seeram, URI assistant professor of biomedical and pharmaceutical sciences and director of the Bioactive Botanical Research Laboratory, said he believes this will be the largest conference of its kind in the history of the University.

"The Northeast Corridor of the United States is the center of pharmaceutical science research and industry and so this is an ideal location for a program of this type," Seeram said. "The participation of some of the world's leading biomedical scientists, including Yale's Professor Steitz, is an indication of the high regard they have for research going on at URI's College of Pharmacy and, indeed, the ongoing scientific work of many of our colleges. We have attracted renowned scientists from every portion of the globe, including researchers in India and Pakistan who have partnerships with us."

Conference co-organizer Keykavous Parang, URI professor of medicinal chemistry and pharmacology, said the conference will offer one of the most dive
'/>"/>

Contact: Dave Lavallee
dlavallee@advance.uri.edu
401-874-5862
University of Rhode Island
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
2. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
3. Kessler Foundation researchers present at first International Congress on Cognition in MS
4. International conference to explore health of descendants of transatlantic slave trade
5. International breast health global summit will focus on supportive care and quality of life
6. MSU invention could help pharmaceutical industry save money
7. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
8. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
9. Blending conference translates substance abuse research into practice
10. NJ stroke researchers report advances in spatial neglect research at AAN Conference
11. Elsevier organizes label-free technologies conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) March 01, 2015 Heart diseases ... that 10 percent of urban adult population and 5 ... of heart diseases and 20-30 percent of them require ... heart ailments and coronary vascular diseases (CVD). , A ... a new market research report titled “Indian Coronary Stent ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The ... is offering a new special. Throughout all of ... , This service can help ... problems and pain. Patients may notice certain symptoms that ... relining. These symptoms include: , 1.    Pain, clicking, and ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 A study ... promising new gene therapy procedure for the treatment of ... in patients. Authored by Dr. Robert MacLaren, ... published in the Lancet Medical Journal on January 16, ... choroideremia, a rare genetic disorder that mostly affects men ...
(Date:2/28/2015)... February 28, 2015 Dr. Perry ... Coast area residents, recently announced a special offer for ... a treatment option for new and established patients at ... with a bright, white smile, Dr. Patel and his ... $299, marked down from the regular price of $450. ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 On ... Phishing Kits Make It Easy For Scammers To Steal Your ... anyone can get their hands on a DIY phishing kit, ... But it also touched on another important point about how ... these kits are often implemented, “like compromising legitimate content management ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... FRIDAY, March 18 (HealthDay News) -- Obstructive sleep apnea may ... with enlarged prostates, a new study suggests. The study ... benign prostate enlargement (BPE) and reported nighttime urination (nocturia) at ... of same-age men who had no BPE and one or ...
... 18 (HealthDay News) -- Women in smoke-free homes and ... breast cancer, new research shows. U.S. researchers compared ... of breast cancer incidence and death. States with higher ... breast cancer deaths, particularly among younger premenopausal women. ...
... College of Radiology,s Imaging Network (ACRIN) and the ... (NCI) Clinical Trials Cooperative Group members, today announced ... programs. The groups plan to form ... new organization will include three areas of research ...
... with different terms to describe a clinical trial, parents were far ... called a "research study" than if it was called a "medical ... the former as safer, even though that was not necessarily the ... Human Research . Terms such as these are ...
... News) -- Anti-drug ads appear to be an effective way ... the United States, a new study has found. In ... Influence" anti-drug campaign, researchers analyzed the relationship between exposure to ... students in grades 8, 10 and 12. The campaign ...
... The federal Centers for Disease Control and Prevention ... Health & Hospitals System and Rush University Medical ... successful program aimed at preventing healthcare-associated infections, antibiotic ... The project, dubbed the Chicago Antimicrobial Resistance and ...
Cached Medicine News:Health News:Sleep Disorder May Spur Men to Head to Bathroom at Night 2Health News:Biomarker-driven science at the heart of new ACRIN-ECOG structure 2Health News:Biomarker-driven science at the heart of new ACRIN-ECOG structure 3Health News:Terminolgy matters in parents' willingness to enroll their children in research 2Health News:CDC, Cook County and Rush collaborate to research and prevent hospital infections 2Health News:CDC, Cook County and Rush collaborate to research and prevent hospital infections 3Health News:CDC, Cook County and Rush collaborate to research and prevent hospital infections 4
(Date:2/27/2015)... HILL, N.C. , Feb. 27, 2015 ... over the past decade but one thing hasn,t changed: ... MSLs to build relationships with Key Opinion Leaders. ... recognized as the most valuable type of interaction, field ... limits on their KOL interactions. This is just one ...
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. ... from a pre-clinical study published in the ... ( www.pnas.org/cgi/doi/10.1073/pnas.1500712112 ) that showed when ibrutinib (IMBRUVICA ... (a checkpoint inhibitor), suppression of tumor growth was ... when treating certain hematologic cancers and solid tumors ...
(Date:2/27/2015)... TEL-AVIV , Israele, February 27, 2015 /PRNewswire/ ... continua nel suo sviluppo dell,innovativo sistema di monitoraggio ... il primo trial sull,uomo-   ... operante nello sviluppo di nuovo sistema per il ... congestizio (CHF), ha annunciato oggi di aver concluso ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... ResMed Inc. (NYSE: RMD ) today announced results ... quarter ended September 30, 2011 was a record $314.8 million, ... basis) over the quarter ended September 30, 2010.  For the ... Largely as a result of currency exchange rate movements, net ...
... of the most crucial components of a successful new ... relationships with the FDA. However, while building a collegial and ... the FDA is not always an easy task, not doing ... study participant, a Regulatory Affairs Executive Director at a leading ...
Cached Medicine Technology:ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011 2ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011 3ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011 4ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011 5ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011 6Recent Research Provides Formula for Timely Product Launch: Good Science + Effective FDA Relations 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: